Vocka, M.; Zimovjanova, M.; Bielcikova, Z.; Tesarova, P.; Petruzelka, L.; Mateju, M.; Krizova, L.; Kotlas, J.; Soukupova, J.; Janatova, M.;
et al. Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers. Cancers 2019, 11, 738.
https://doi.org/10.3390/cancers11060738
AMA Style
Vocka M, Zimovjanova M, Bielcikova Z, Tesarova P, Petruzelka L, Mateju M, Krizova L, Kotlas J, Soukupova J, Janatova M,
et al. Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers. Cancers. 2019; 11(6):738.
https://doi.org/10.3390/cancers11060738
Chicago/Turabian Style
Vocka, Michal, Martina Zimovjanova, Zuzana Bielcikova, Petra Tesarova, Lubos Petruzelka, Martin Mateju, Ludmila Krizova, Jaroslav Kotlas, Jana Soukupova, Marketa Janatova,
and et al. 2019. "Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers" Cancers 11, no. 6: 738.
https://doi.org/10.3390/cancers11060738
APA Style
Vocka, M., Zimovjanova, M., Bielcikova, Z., Tesarova, P., Petruzelka, L., Mateju, M., Krizova, L., Kotlas, J., Soukupova, J., Janatova, M., Zemankova, P., Kleiblova, P., Novotny, J., Konopasek, B., Chodacka, M., Brychta, M., Sochor, M., Smejkalova-Musilova, D., Cmejlova, V.,
... Kleibl, Z.
(2019). Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers. Cancers, 11(6), 738.
https://doi.org/10.3390/cancers11060738